The Patients for Affordable Drugs says that where its money can’t help decide a race, it can still send a message: that politicians running campaigns funded by drug companies will face retribution. But some experts are dubious. In other pharmaceutical news: a lobbying firm behind a shadowy drug organization is revealed, pharma gets a boost after a New Jersey court dismisses hundreds of lawsuits, and patent laws are getting attention in the fight over prices.
from Kaiser Health News https://ift.tt/2PaZIEV
0 comments:
Post a Comment